Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012 (2012), Article ID 412742, 5 pages
http://dx.doi.org/10.1155/2012/412742
Clinical Study

RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution

1Department of Haematology, Miguel Servet University Hospital, Zaragoza, Spain
2Department of Nuclear Medicine, Miguel Servet University Hospital, Zaragoza, Spain
3Instituto Aragonés de Ciencias de la Salud (I+CS), Zaragoza, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). Zaragoza, Spain

Received 3 March 2012; Revised 6 July 2012; Accepted 2 August 2012

Academic Editor: Paul G. Richardson

Copyright © 2012 Marcio Miguel Andrade Campos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Marcio Miguel Andrade Campos, Anel E. Montes Limón, Jose María Grasa, Paola Lievano, Teresa Baringo, and Pilar Giraldo, “RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution,” Journal of Oncology, vol. 2012, Article ID 412742, 5 pages, 2012. doi:10.1155/2012/412742